Quick answer
Can you take Wegovy with Levothyroxine (Synthroid)? Moderate interaction — use with caution and prescriber awareness; monitoring recommended. Mechanism: Levothyroxine has a narrow therapeutic window and absorption is sensitive to gastric conditions and timing. GLP-1-induced delayed gastric emptying and weight loss can shift levothyroxine requirements, with potential for either under- or ove…
- Severity
- moderate
- Interaction type
- pharmacokinetic
- Monitoring focus
- TSH about 6-8 weeks after starting semaglutide and after each significant weight change, per prescriber.
Always confirm with your prescriber. This is educational and based on FDA label data.
Key takeaways
- • Severity: Moderate — adjust timing or dose.
- • Wegovy (weight management (FDA-approved obesity)) and Levothyroxine (Synthroid) (Thyroid hormone replacement).
- • Clinical management: Maintain consistent administration (empty stomach, separated from food and other meds). The prescriber rechecks TSH and adjusts dose as weight changes.
- • Monitoring: TSH about 6-8 weeks after starting semaglutide and after each significant weight change, per prescriber.
Mechanism
Levothyroxine has a narrow therapeutic window and absorption is sensitive to gastric conditions and timing. GLP-1-induced delayed gastric emptying and weight loss can shift levothyroxine requirements, with potential for either under- or over-replacement. Significant weight changes also alter the required dose because levothyroxine is weight-based.
Clinical management
Maintain consistent administration (empty stomach, separated from food and other meds). The prescriber rechecks TSH and adjusts dose as weight changes.
GLP1Zoom does not prescribe medications or recommend dose changes. Always confirm any adjustment with your prescribing clinician before changing how you take Wegovy or Levothyroxine (Synthroid).
Monitoring checklist
What to monitor + when to call your prescriber
Routine monitoring
- TSH about 6-8 weeks after starting semaglutide and after each significant weight change, per prescriber
Call prescriber urgently if
- new fatigue, cold intolerance, weight gain (under-replacement)
- palpitations, tremor, heat intolerance, insomnia (over-replacement)
Deeper clinical context
Time course, adjustment scenarios, and subgroup considerations — for prescriber-led discussion. GLP1Zoom does not prescribe; defer to your clinician.
Time course
- Onset
- TSH typically rises 4-8 weeks after GLP-1 initiation if levothyroxine absorption is materially reduced. Mechanism: delayed gastric emptying reduces fractional absorption of the morning levothyroxine dose.
- Peak
- TSH peak elevation usually occurs after the GLP-1 reaches maintenance dose (week 12-16 for semaglutide; week 8-12 for tirzepatide).
- Resolution
- TSH normalizes 4-8 weeks after either GLP-1 discontinuation or levothyroxine dose-increase adjustment.
Dose-adjustment scenarios
Generic clinical patterns prescribers commonly use. Your individual plan may differ.
Patient on chronic levothyroxine starting GLP-1
Many endocrinologists check TSH at baseline and again at 12 weeks post-GLP-1 initiation. If TSH rises >50% from baseline, levothyroxine dose is typically increased by 12.5-25 mcg. Some prescribers preemptively increase levothyroxine by 12.5 mcg if baseline TSH is already in upper-normal range.
Patient on tight TSH targets (e.g. post-thyroidectomy for cancer)
For TSH suppression therapy, more frequent monitoring (every 6 weeks during GLP-1 titration) is often appropriate. Levothyroxine dose adjustments are reactive to lab values.
Patient subgroup considerations
Pregnant patients
Pregnancy itself increases levothyroxine requirements. Combining pregnancy + GLP-1 would compound the absorption issue, but GLP-1 medications are generally contraindicated in pregnancy regardless.
Patients with established osteoporosis on TSH suppression
Undertreatment risks hypothyroid bone loss; overtreatment risks osteoporotic worsening. Monitoring frequency должно be increased.
Real-world example: levothyroxine + semaglutide
A 54-year-old with hypothyroidism on levothyroxine 100 mcg daily (baseline TSH 2.1) starts semaglutide 0.25mg weekly.
- Endocrinologist instructs patient to maintain consistent levothyroxine timing (30-60 min before breakfast) and not take alongside semaglutide injection
- TSH checked at week 12: rose to 4.8 (above patient-specific target of 2.5)
- Levothyroxine increased to 112 mcg daily
- TSH at week 24: 2.3 — back to target on semaglutide 1.0mg + levothyroxine 112 mcg
- KEY POINT: routine TSH monitoring frequency was increased during the GLP-1 titration phase, not a pre-emptive levothyroxine adjustment
Alternatives to discuss
Alternative GLP-1s to discuss with your prescriber
A moderateinteraction warrants conversation. Your prescriber may suggest a different GLP-1 if this one isn't right for your full medication profile. We don't prescribe — these are conversation starters.
- Zepbound(tirzepatide)View page →
- Ozempic(semaglutide)View page →
- Mounjaro(tirzepatide)View page →
- Rybelsus(oral semaglutide)View page →
- Saxenda(liraglutide)View page →
Different GLP-1 molecules (semaglutide vs tirzepatide vs liraglutide) have somewhat different interaction profiles. A different class may have less concerning interaction with your other medication.
When to call your doctor
- new fatigue, cold intolerance, weight gain (under-replacement)
- palpitations, tremor, heat intolerance, insomnia (over-replacement)
In emergencies — severe abdominal pain, persistent vomiting, fainting, signs of severe hypoglycemia (confusion, seizures), or signs of bleeding — call 911 or go to the nearest emergency department.
Source / FDA label citation
Not specifically listed as an interaction in current FDA label; weight-based dosing is standard levothyroxine practice.
Editorial confidence: 7/10. Lower scores reflect inferred mechanism rather than directly-labeled interaction. We re-verify against the active FDA prescribing information at least every 6 months.
References
FDA Guidance for Industry: Clinical Drug Interaction Studies(2020)
GLP-1 Receptor Agonist Drug Interactions: Comprehensive Review (Diabetes Therapy)(2023)
DailyMed (NIH): FDA Prescribing Information Repository(2024)
Glucagon-Like Peptide-1 Receptor Agonists: Mechanisms and Clinical Use (Drucker, Cell Metabolism)(2018)
Tirzepatide GIP/GLP-1 Dual Agonism: Mechanism Review (Lancet Diabetes & Endocrinology)(2021)
GLP-1 Effects on Gastric Emptying: Pharmacology Review (American J Physiology)(2020)
Common questions
Can I take Levothyroxine (Synthroid) with Wegovy?
Clinically meaningful — typically managed with dose/timing changes. Maintain consistent administration (empty stomach, separated from food and other meds). The prescriber rechecks TSH and adjusts dose as weight changes. Always confirm the specific plan with your prescriber — this page summarizes general pharmacology, not personal medical advice.
What's the mechanism of any Wegovy + Levothyroxine (Synthroid) interaction?
Levothyroxine has a narrow therapeutic window and absorption is sensitive to gastric conditions and timing. GLP-1-induced delayed gastric emptying and weight loss can shift levothyroxine requirements, with potential for either under- or over-replacement. Significant weight changes also alter the required dose because levothyroxine is weight-based.
What should I monitor when on Wegovy + Levothyroxine (Synthroid)?
TSH about 6-8 weeks after starting semaglutide and after each significant weight change, per prescriber.
When should I call my doctor?
Contact your prescriber if you notice any of: new fatigue, cold intolerance, weight gain (under-replacement); palpitations, tremor, heat intolerance, insomnia (over-replacement).
Related
This page summarizes general pharmacology from FDA-approved prescribing information. It is not a substitute for personalized medical advice. GLP1Zoom is an affiliate-only comparator — we do not prescribe or sell medications. Full disclaimer.